These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11757278)

  • 21. Renal effects of angiotensin-I converting enzyme inhibitors.
    Gans RO; Hoorntje SJ; Donker AJ
    Neth J Med; 1988 Jun; 32(5-6):247-64. PubMed ID: 3292962
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP; Rumley A; Lowe GD; McMurray JJ
    Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract]   [Full Text] [Related]  

  • 23. [Angiotensin II antagonists: a promising pathway].
    Cohen-Solal A
    Arch Mal Coeur Vaiss; 2000 Jun; Spec No():10-1, 15. PubMed ID: 10949700
    [No Abstract]   [Full Text] [Related]  

  • 24. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin-converting enzyme inhibitor trandolapril does not affect C-reactive protein levels in myocardial infarction patients.
    de Maat MP; Kluft C; Gram J; Jespersen J
    Circulation; 2003 Oct; 108(15):e113. PubMed ID: 14557351
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of hypertension in patients with cardiac disease: use of renin-angiotensin blocking agents.
    Prisant LM
    Am J Med; 2008 Aug; 121(8 Suppl):S8-15. PubMed ID: 18638617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [CAPRICORN and COPERINUS studies].
    Juillière Y
    Arch Mal Coeur Vaiss; 2002 Feb; 95 Spec 4(5 Spec 4):17-20. PubMed ID: 11933550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prospective trends in the study of the therapeutic action of angiotensin-converting enzyme inhibitors in cardiovascular diseases].
    Novikova LS; Arabidze GG
    Ter Arkh; 1990; 62(1):118-23. PubMed ID: 2159193
    [No Abstract]   [Full Text] [Related]  

  • 29. [Angiotensin-converting enzyme inhibitors in the treatment of heart failure: toward a change in the natural history of the disease].
    Martín Luengo C; Arribas Jiménez A; Nieto Ballestero F; Diego Domínguez M; Cascón Bueno M; Pabón Osuna P; Sala Sánchez-Castillo A
    Rev Esp Cardiol; 1993 Mar; 46(3):131-45. PubMed ID: 8488316
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? AT1-receptor antagonists?
    Hoppe UC
    Clin Res Cardiol; 2007 Apr; 96(4):196-8. PubMed ID: 17294351
    [No Abstract]   [Full Text] [Related]  

  • 31. [Inhibition of angiotensin converting enzyme: a decade's experience].
    Martínez Amenós A
    Med Clin (Barc); 1990 Jun; 95(4):143-6. PubMed ID: 2250536
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cardiovascular pharmacology (IX). Angiotensin-converting enzyme inhibitors in hypertension and heart failure].
    de Teresa E; Espinosa JS; Gómez Doblas JJ
    Rev Esp Cardiol; 1995 Feb; 48(2):128-41. PubMed ID: 7886264
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-ischemic properties of ACE-inhibitors.
    Deedwania PC
    Cardiologia; 1996 Mar; 41(3):209-15. PubMed ID: 8697478
    [No Abstract]   [Full Text] [Related]  

  • 35. [ACE-inhibitors in renal protection].
    Barna I
    Orv Hetil; 2006 Jun; 147(22):1019-23. PubMed ID: 16913091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The OPTIMAAL study, not so optimal: the lessons of LIFE, RENAAL and IDNT.
    Lapointe N; Pourdjabbar A; Rouleau JL
    Can J Cardiol; 2003 Aug; 19(9):994-6. PubMed ID: 12915925
    [No Abstract]   [Full Text] [Related]  

  • 37. Angiotensin-converting-enzyme inhibitors in the treatment of hypertension.
    Coats AJ
    Br J Hosp Med; 1987 Dec; 38(6):531-2, 536-41. PubMed ID: 2829986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials.
    Greenberg BH
    J Card Fail; 2002 Dec; 8(6 Suppl):S486-90. PubMed ID: 12555162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correction of postinfarction remodelling of the heart with angiotensin-converting enzyme inhibitors].
    Giliarevskiĭ SR; Orlov VA; Gvindzhiliia TV
    Kardiologiia; 1993; 33(12):37-47. PubMed ID: 8196256
    [No Abstract]   [Full Text] [Related]  

  • 40. Trandolapril in patients with left ventricular dysfunction after myocardial infarction.
    Neumayr G; Gänzer J
    N Engl J Med; 1996 Jun; 334(23):1546. PubMed ID: 8618619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.